scholarly journals Sexually transmitted infections, bacterial vaginosis, and candidiasis in women of reproductive age in rural Northeast Brazil: a population-based study

2007 ◽  
Vol 102 (6) ◽  
pp. 751-756 ◽  
Author(s):  
Fabíola Araújo Oliveira ◽  
Viola Pfleger ◽  
Katrin Lang ◽  
Jörg Heukelbach ◽  
Iracema Miralles ◽  
...  
Author(s):  
Durga K. ◽  
Karthika K.

Background: Sexually transmitted infections (STIs) present a huge burden of disease and adversely affect the reproductive health of people. The disease prevalence is about 6% in India. This study is done to determine the prevalence of STIs in women of reproductive age (15-49yrs) attending gynaec outpatient block at Institute of Obstetrics and Gynaecology, Chennai and to identify the risk factors.Methods: It is a prospective analytical study conducted at IOG from Febraury 2010 to January 2011 where 1000 women of reproductive age attending gynec op were included of which 500 women were asymptomatic and 500 women were symptomatic for STIs. A well-structured proforma was prepared for selection of women, history, examination, investigations and treatment. Asymptomatic women were also screened and treated. Partners were also screened and treated. Depending upon the statistical data, the risk factors were identified and analysed.Results: Overall prevalence of STI was 27.2% of which 22.5% was in symptomatic group and 4.7% in asymptomatic group. Bacterial vaginosis was the commonest STI. The important risk factors identified were age group between 26-30 years, high risk sexual behaviours, poor socioeconomic factors, poor menstrual hygiene and lack of contraception.Conclusions: STIs cause major health problem and it is important to diagnose and treat them at the earliest. The importance of STIs has been more widely recognised since the advent of the HIV/AIDS epidemic, and there is good evidence that their control can reduce HIV transmission. Women diagnosed with one STI should be screened for other STI due to coexistant infections. Screening and treatment of partners and follow-up tests of cure should be performed wherever possible.


PLoS ONE ◽  
2020 ◽  
Vol 15 (1) ◽  
pp. e0224359 ◽  
Author(s):  
Raina N. Fichorova ◽  
Charles S. Morrison ◽  
Pai-Lien Chen ◽  
Hidemi S. Yamamoto ◽  
Yashini Govender ◽  
...  

2003 ◽  
Vol 56 (1) ◽  
pp. 111-124 ◽  
Author(s):  
Edgar Iglesias ◽  
Eva Robertson ◽  
Sven-Erik Johansson ◽  
Peter Engfeldt ◽  
Jan Sundquist

PLoS ONE ◽  
2017 ◽  
Vol 12 (12) ◽  
pp. e0188677 ◽  
Author(s):  
Lovney Kanguru ◽  
Affette McCaw-Binns ◽  
Jacqueline Bell ◽  
Novie Yonger-Coleman ◽  
Rainford Wilks ◽  
...  

2003 ◽  
Vol 52 (2) ◽  
pp. 145-150
Author(s):  
G. V. Grinenko ◽  
Alevtina M. Savicheva

The article presents the review of modem literature dedicated epidemiological data and risk factors of sexually transmitted infections in women of reproductive age.


Author(s):  
Xiaodi Chen ◽  
Yune Lu ◽  
Tao Chen ◽  
Rongguo Li

The vaginal microbiome is an intricate and dynamic microecosystem that constantly undergoes fluctuations during the female menstrual cycle and the woman’s entire life. A healthy vaginal microbiome is dominated by Lactobacillus which produce various antimicrobial compounds. Bacterial vaginosis (BV) is characterized by the loss or sharp decline in the total number of Lactobacillus and a corresponding marked increase in the concentration of anaerobic microbes. BV is a highly prevalent disorder of the vaginal microbiota among women of reproductive age globally. BV is confirmed to be associated with adverse gynecologic and obstetric outcomes, such as sexually transmitted infections, pelvic inflammatory disease, and preterm birth. Gardnerella vaginalis is the most common microorganism identified from BV. It is the predominant microbe in polymicrobial biofilms that could shelter G. vaginalis and other BV-associated microbes from adverse host environments. Many efforts have been made to increase our understanding of the vaginal microbiome in health and BV. Thus, improved novel and accurate diagnosis and therapeutic strategies for BV have been developed. This review covers the features of vaginal microbiome, BV, BV-associated diseases, and various strategies of diagnosis and treatment of BV, with an emphasis on recent research progresses.


Sign in / Sign up

Export Citation Format

Share Document